DRTÍLKOVÁ, Ivana, Pavel THEINER and Josef BLAŽEK. Risperidone in children and adolescents with conduct disorders. European Neuropsychopharmacology. 2002, 12/2002, 9.10.2002, p. 424;425, 2 pp. ISSN 0924-977X.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Risperidone in children and adolescents with conduct disorders
Authors DRTÍLKOVÁ, Ivana (203 Czech Republic, guarantor), Pavel THEINER (203 Czech Republic) and Josef BLAŽEK (203 Czech Republic).
Edition European Neuropsychopharmacology, 2002, 0924-977X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30000 3. Medical and Health Sciences
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.492
RIV identification code RIV/00216224:14330/02:00007122
Organization unit Faculty of Informatics
Keywords in English risperidone; children; conduct disorders
Tags children, conduct disorders, risperidone
Changed by Changed by: RNDr. JUDr. Vladimír Šmíd, CSc., učo 1084. Changed: 31/5/2003 10:05.
Abstract
We initiated a retrospective study in order to examine the safety, tolerability and efficacy of risperidone in children and adolscents with conduct disorders. The sample included 34 patinets, dosis of risperidone were 1,29mg/day in average. Risperidone appeared to be safe and effective in ameliorating symptoms of conduct disorders in this age group.
Links
NF6520, research and development projectName: Klinické a molekulárně-biologické koreláty hyperkinetické poruchy v dětském věku
Investor: Ministry of Health of the CR, Clinical and molecular-biological correlates of attention deficit hyperactivity disorder in children
PrintDisplayed: 9/7/2024 19:31